Aytu Biopharma (AYTU) Liabilities from Discontinued Operations (2024)
Aytu Biopharma (AYTU) reported Liabilities from Discontinued Operations of 557000.0 for Q2 2024.
Aytu Biopharma (AYTU) Liabilities from Discontinued Operations (2024) Analysis & Trends
Aytu Biopharma (AYTU) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 557000.0 in Q2 2024.
- Liabilities from Discontinued Operations for Q2 2024 came in at 557000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was 557000.0 (changed N/A YoY), and the FY2024 annual result was 557000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations held at 557000.0 in Q2 2024 per AYTU's latest filing.
- Over five years, Liabilities from Discontinued Operations peaked at 557000.0 in Q2 2024 and troughed at 557000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 557,000.00 |
| Jun 30, 2024 | 557,000.00 |